Cathérine Belin

ORCID: 0000-0003-4975-4578
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Neurobiology of Language and Bilingualism
  • Meningioma and schwannoma management
  • Alzheimer's disease research and treatments
  • Cancer-related cognitive impairment studies
  • CAR-T cell therapy research
  • Ophthalmology and Eye Disorders
  • Natural product bioactivities and synthesis
  • Neuroscience and Music Perception
  • Pituitary Gland Disorders and Treatments
  • Lung Cancer Research Studies
  • Neuroscience and Neuropharmacology Research
  • Visual perception and processing mechanisms
  • Multiple Sclerosis Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Health disparities and outcomes
  • Hormonal Regulation and Hypertension
  • Migraine and Headache Studies
  • Health, Medicine and Society
  • Stroke Rehabilitation and Recovery
  • Nanowire Synthesis and Applications
  • Ginseng Biological Effects and Applications
  • Radiopharmaceutical Chemistry and Applications

Hôpital Saint-Louis
2018-2025

Assistance Publique – Hôpitaux de Paris
2015-2024

Université Paris Cité
2000-2023

Université de Lille
2022

Hôpital Fernand-Widal
2021-2022

Université de Strasbourg
2022

Cognitive Neuroimaging Lab
2022

Hôpital Avicenne
2010-2021

Centre National de la Recherche Scientifique
2000-2021

Université Paris-Saclay
2021

Abstract Chimeric antigen receptor-modified T (CAR T) cell therapy is a highly promising treatment for haematological malignancies but frequently associated with cytokine release syndrome and neurotoxicity. Between July 2018 2019, all patients treated CD19-targeted CAR T-cell relapsing lymphoma were followed-up longitudinally to describe neurological symptoms their evolution over time. Four different French centres participated 84 (median age 59 years, 31% females) included. Neurotoxicity,...

10.1038/s41598-020-76055-9 article EN cc-by Scientific Reports 2020-11-04

Approximately 10% of patients with non-small cell lung cancer (NSCLC) have brain metastases at the time diagnosis. When surgical resection is not possible, whole radiotherapy standard care, a cerebral response rate approximately 30%. We report our experience an upfront association carboplatin and pemetrexed (areas under curve, 5 500 mg/m2, respectively), every 3 weeks, in 30 presenting newly diagnosed NSCLC. Cerebral MRIs were performed 6–9 weeks. The radiologic rates assessed according to...

10.1093/neuonc/nos004 article EN Neuro-Oncology 2012-02-22

Isolated subjective cognitive impairment (SCI) and mild (MCI) are the prodromal phases of dementia with Lewy bodies (DLB). MEMENTO is a nationwide study patients SCI MCI clinic, neuropsychology, biology, brain imaging data. We aimed to compare symptoms DLB others in this at baseline.Participants French cohort were recruited for either or MCI. Among them, 892 included sub-study, designed search specifically DLB. Probable diagnosis (pro-DLB group) was done using two-criteria cutoff score among...

10.1186/s13195-022-01037-0 article EN cc-by Alzheimer s Research & Therapy 2022-07-19

PURPOSE: To document the changes observed at sequential magnetic resonance (MR) imaging of sarcoidosis lesions central nervous system (CNS) during treatment with corticosteroids. MATERIALS AND METHODS: The abnormalities detected in 24 patients (mean follow-up, 36 months) were compared before and after therapeutic periods (n = 75) that divided into attack (high-dose), upkeep (decreased-dose), minimal (low-dose) periods. Parenchymal classified as type 1 (enhanced gadolinium), 2...

10.1148/radiology.214.2.r00fe05411 article EN Radiology 2000-02-01

Although previous studies suggest that music may facilitate verbal learning in a healthy population, such mnemonic effect has seldom been investigated Alzheimer's disease (AD). Moreover, memorization of texts was generally compared when either sung or spoken. In the present study, it examined whether benefit observed on specific to an associative context binding items together led similar benefits, regardless nature association.Twelve patients with mild AD and 15 controls learned presented...

10.1080/13803395.2015.1026802 article EN Journal of Clinical and Experimental Neuropsychology 2015-05-08

The natural history and disease mechanisms of Alzheimer's related disorders (ADRD) are still poorly understood. Very few resources available to scrutinise patients as early needed use integrative approaches combining standardised, repeated clinical investigations cutting-edge biomarker measurements.In the nationwide French MEMENTO cohort study, participants were recruited in memory clinics screened for either isolated subjective cognitive complaints (SCCs) or mild impairment (MCI; defined...

10.1186/s13195-017-0288-0 article EN cc-by Alzheimer s Research & Therapy 2017-08-29

Objective To assess progression of semantic loss in early stages cognitive decline using and letter fluency performance, its relation with Alzheimer's disease (AD)-specific neurodegeneration longitudinal multimodal neuroimaging measures. Methods Change verbal was analyzed among 2261 non-demented individuals a follow-up diagnosis no mild impairment (MCI), amnestic MCI (aMCI), non-amnestic (naMCI), or incident dementia, linear mixed models across 4 years follow-up, relations magnetic resonance...

10.1002/dad2.12066 article EN cc-by Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2020-01-01

Chimeric antigen receptor-modified T (CAR T) cells are profoundly changing the standard of care in B-cell malignancies. This new therapeutic class induces a significant number acute neurotoxicity, but data regarding mid- and long-term neurological safety scarce. We evaluated mid-term safety, with special emphasis on cognitive functions, series adults treated CAR cells.Patients single center CD19-targeted for relapsing lymphoma were prospectively followed up by neurologists. Before T-cell...

10.1093/neuonc/noab077 article EN Neuro-Oncology 2021-03-30

Abstract Objective Emotion recognition tests are essential for differential diagnostics when assessing patients with Alzheimer’s disease (AD) dementia. However, there remains a lack of emotion appropriate culturally and educationally diverse populations. The aim this study was to develop an test (the TIE-93) these We then examined whether the TIE-93 could reduce performance differences between populations native French versus background (participants who had immigrated France). This assessed...

10.1093/arclin/acaf012 article EN Archives of Clinical Neuropsychology 2025-02-20
Vincent Bouteloup Nicolas Villain Jean‐Sébastien Vidal Fernándo González‐Ortiz Idil Yuksekel and 95 more Cristiano Santos Susanna Schraen-Maschken Isabelle Pellegrin Sylvain Lehmann Kaj Blennow Geneviève Chêne Olivier Hanon Carole Dufouil Vincent Planche Isabelle Addra Michèle Allard Sandrine Andrieu Pierre Anthony Christine Astier A. Augier Nicolas Auguste Sophie Auriacombe John Avet Chabha Azouani Olivier Bailon Anna‐Chloé Balageas Fabrice-Guy Barral Jean Barré A. Barthelaix Catherine Bayle Olivier Beauchet Serge Belliard Cathérine Belin Samia Belkacem Hugo Bertin D. Ben Salem Karim Bennys G. Béra Éric Berger Marc Berger Emilie Bergouin François Bertin‐Hugault Guillaume Bertrand F Bertrand Catherine Beze Valérie Boilet Stéphanie Bombois Alain Bonafé Yasmina Boudali Hatem Bouhladour Clémence Boully Isabelle Bourdel‐Marchasson Vincent Bouteloup Claire Boutet Christophe Bouvier Laïla Bouzid Serge Bracard Antoine Brangier Pierre‐Yves Brillet Laure Caillard Fabienne Calvas Agnès Camus Vincent Camus Sandrine Canaple Alexandre Cantan Alain Carpentier Pascaline Cassagnaud F. Cattin Ludivine Chamard S. Chanalet Mathieu Chastan Sophie Chauvelier Valérie Chauviré Geneviève Chêne Samia Cheriet Marie Chupin Anthony Clotagatide Emmanuel Cognat Lora Cohen Jean‐Marc Constans Marie-Hélène Coste Jean‐Philippe Cottier François Cotton I. Couret Olivier Couturier Pascale Cowppli-Bony V. Cressot Benjamin Crétin Keren Danaila Jacques Darcourt Jean-François Dartigues Ana-Maria Dăscaliţa Renaud David Samuel David Xavier De Petigny Delphine De Verbizier-Lonjon M. Décousus Isabelle Defouilloy Christine Delmaire Julien Delrieu

Importance Blood phosphorylated tau 217 (p-tau217) showed good performance in predicting brain amyloidosis. However, the importance of detailed cognitive phenotyping patients without dementia when interpreting p-tau217 results remains unclear. Objective To assess whether accuracy, negative predictive value (NPV), and positive (PPV) amyloidosis using varies across clinical presentations dementia. Design, Setting, Participants The study design included 2 observational, prospective cohort...

10.1001/jamaneurol.2025.0142 article EN JAMA Neurology 2025-04-04
Éric Frison Cécile Proust‐Lima Jean‐François Mangin Marie‐Odile Habert Stéphanie Bombois and 95 more Pierre‐Jean Ousset Florence Pasquier Olivier Hanon Claire Paquet Audrey Gabelle Mathieu Ceccaldi Cédric Annweiler Pierre Krolak‐Salmon Yannick Béjot Cathérine Belin David Wallon Mathilde Sauvée É. Beaufils Isabelle Bourdel‐Marchasson Isabelle Jalenques Marie Chupin Geneviève Chêne Carole Dufouil Michèle Allard Sandrine Andrieu Pierre Anthony Christine Astier A. Augier Nicolas Auguste Sophie Auriacombe John Avet Olivier Bailon Fabrice-Guy Barral Jean Barré A. Barthelaix Catherine Bayle Olivier Beauchet Samia Belkacem D. Ben Salem Karim Bennys G. Béra Éric Berger Marc Berger Emilie Bergouin François Bertin‐Hugault Guillaume Bertrand F Bertrand Catherine Beze Valérie Boilet Alain Bonafé Yasmina Boudali Hatem Bouhladour Clémence Boully Vincent Bouteloup Claire Boutet Serge Bracard Antoine Brangier Pierre‐Yves Brillet Laure Caillard Fabienne Calvas Agnès Camus Vincent Camus Sandrine Canaple Alain Carpentier Pascaline Cassagnaud F. Cattin Ludivine Chamard Stéphane Chanalet Mathieu Chastan Sophie Chauvelier Valérie Chauviré Samia Cheriet Anthony Clotagatide Emmanuel Cognat Lora Cohen Jean‐Marc Constans Marie-Hélène Coste Jean‐Philippe Cottier François Cotton I. Couret Olivier Couturier Pascale Cowppli-Bony V. Cressot Benjamin Crétin Keren Danaila Jacques Darcourt Jean-François Dartigues Ana-Maria Dăscaliţa Renaud David Xavier De Petigny Delphine De Verbizier-Lonjon M. Décousus Isabelle Defouilloy Christine Delmaire Julien Delrieu Catherine Demuyinck Vincent Deramecourt Hervé Deramond Thomas Desmidt Marie-Dominique Desruet

To assess the role of biomarkers Alzheimer disease (AD), neurodegeneration, and small vessel (SVD) as mediators in association between diabetes mellitus cognition. The study sample was derived from MEMENTO, a cohort French adults recruited memory clinics screened for either isolated subjective cognitive complaints or mild impairment. Diabetes defined based on blood glucose assessment, use antidiabetic agent, self-report. We used structural equation modeling to whether latent variables AD...

10.1212/wnl.0000000000012440 article EN cc-by-nc-nd Neurology 2021-07-01

To assess subclinical central nervous system (CNS) involvement in primary Sjögren syndrome (pSS), by comparing standard brain MRI, in-depth neuropsychological testing and (99m)Tc-ECD single-photon emission computed tomography (SPECT) of patients with pSS matched controls.10 women (<55 years old), defined using European-American criteria, presence anti-SSA and/or anti-SSB antibodies no history neurological were prospectively investigated, compared 10 age- sex-matched controls. All subjects...

10.1136/ard.2008.090811 article EN Annals of the Rheumatic Diseases 2009-01-21

Despite surgery, radiotherapy (RT) and temozolomide (TMZ), the prognosis of glioblastoma (GBM) patients remains dismal. Normally prescribed with aim to lower blood pressure, angiotensin-II (Ang-II) inhibitors were reported reduce angiogenesis tumour growth in several models including one glioma. Thus whether treatment Ang-II could be associated a better clinical outcome GBM was investigated.A series 81 consecutive patients, homogeneously treated RT TMZ for newly diagnosed, supratentorial...

10.1111/ene.12746 article EN European Journal of Neurology 2015-06-04

To validate the TNI-93 test in illiterate and low-educated subjects by setting cutoff scores to discriminate non-demented demented a clinical (CESILL) verifying adequacy of these population-based study (AMI cohort).We used two samples. First, comprising normal elderly participants patients, mostly multicultural, low educated, or illiterate, was compute for detection dementia. Second, AMI cohort, cohort retired farmers living rural setting, as replication study, assess properties different...

10.1093/arclin/acw065 article EN Archives of Clinical Neuropsychology 2016-09-01

Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is a promising treatment in relapsing B-cell lymphoma but frequently associated with acute neurotoxicity. Neurologic long-term safety has not been thoroughly assessed.All patients consecutive refractory admitted our center for CAR underwent neurologic examination, extensive neuropsychological assessment, and brain MRI (except 1 patient) completed self-administrated questionnaires at baseline. The who remained disease-free 2 years were...

10.1212/wnl.0000000000201083 article EN Neurology 2022-07-18

The standard of care in patients with glioblastoma (GBM) relies on surgical resection, radiation therapy (RT), and temozolomide. Steroids are required almost all to reduce peritumoral edema, but associated numerous side effects. Vascular endothelial growth factor (VEGF) is a key driver edema angiogenesis human GBM. Recently, angiotensin-II inhibitors were reported VEGF secretion tumor some animal models.To investigate whether might have similar effect humans before undertaking prospective...

10.1111/j.1468-1331.2012.03766.x article EN European Journal of Neurology 2012-05-31

TLR-9 agonists are immunostimulating agents that have antitumor effects in animal models. A phase I trial was conducted to define the safety profile of subcutaneous injections, combined with intrathecally administration CpG-28, a TRL 9 agonist, patients neoplastic meningitis (NM). Cohorts 3-6 NM were treated for 5 weeks escalating doses CpG-28. The primary endpoint tolerance. Secondary endpoints progression free survival (PFS) and overall (OS). Twenty-nine cancers malignant glioma, lung...

10.1111/cas.12724 article EN cc-by-nc-nd Cancer Science 2015-06-19

Immune-checkpoint inhibitors (ICIs) targeting cytotoxic T lymphocyte-associated antigen-4 and programmed cell death ligand-1) are associated with several immune-related neurological disorders. Cases of meningitis related to ICIs poorly described in literature probably underestimated. Several guidelines available for the acute management these adverse events, but safety resuming patients remains unclear. We conducted a retrospective case series that occurred between October 1 2015 31 2019 two...

10.1136/jitc-2020-001034 article EN cc-by-nc Journal for ImmunoTherapy of Cancer 2020-07-01

To compare the administration of neuropsychological tests by teleneuropsychology (TeleNP) and face to (F-F) in order determine feasibility reliability TeleNP. At inclusion visit, all participants underwent a traditional F-F assessment as part their standard care. Four months after inclusion, they were randomized undergo an additional either or A total 150 adults with cognitive complaints, but no major sensorial impairment included. 4 months, 69 arm 71 TeleNP (10 lost follow-up). The overall...

10.1017/s1355617721000679 article EN Journal of the International Neuropsychological Society 2021-05-24
Coming Soon ...